FDAFDA · Food and drugs·Recall number D-181-2013
ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35
Published March 13, 2013 · Recall initiated: November 2, 2012
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.
What to do
Voluntary: Firm initiated · Telephone
Recall details
- Brand
- ABILIFY
- Manufacturer
- Bristol Myers Squibb Manufacturing Company
- Distributor
- LA, TN, CA
- Lot
- 2E69023A, Exp. FEB 28 2015
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.